Matches in Wikidata for { <http://www.wikidata.org/entity/Q37335564> ?p ?o ?g. }
- Q37335564 description "article científic" @default.
- Q37335564 description "article scientifique" @default.
- Q37335564 description "articolo scientifico" @default.
- Q37335564 description "artigo científico" @default.
- Q37335564 description "artículu científicu espublizáu en 2016" @default.
- Q37335564 description "bilimsel makale" @default.
- Q37335564 description "scientific article published on 13 October 2016" @default.
- Q37335564 description "vedecký článok" @default.
- Q37335564 description "vetenskaplig artikel" @default.
- Q37335564 description "videnskabelig artikel" @default.
- Q37335564 description "vědecký článek" @default.
- Q37335564 description "wetenschappelijk artikel" @default.
- Q37335564 description "wissenschaftlicher Artikel" @default.
- Q37335564 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q37335564 description "научни чланак" @default.
- Q37335564 description "مقالة علمية نشرت في 13 أكتوبر 2016" @default.
- Q37335564 name "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 name "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 name "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 type Item @default.
- Q37335564 label "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 label "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 label "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 prefLabel "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 prefLabel "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 prefLabel "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 P1433 Q37335564-453B6EC7-7146-4DC0-B76E-E63ED0DDB7E0 @default.
- Q37335564 P1476 Q37335564-51C14DEF-E4DA-4FD2-8208-179A46722C96 @default.
- Q37335564 P2860 Q37335564-058B0074-CA78-4C59-96F8-3886796BAF22 @default.
- Q37335564 P2860 Q37335564-06E29A0C-E49D-4162-8B4E-BAAF22BC7A9C @default.
- Q37335564 P2860 Q37335564-0F230D85-FA18-4BC3-9942-2D3023760DF7 @default.
- Q37335564 P2860 Q37335564-19D33C34-E1E2-452C-A4C3-017BF7CF019B @default.
- Q37335564 P2860 Q37335564-1F31379F-C379-4F82-865F-ACA4099BB064 @default.
- Q37335564 P2860 Q37335564-2C3DD578-7ED8-4B6D-BD7A-F5A9C141A9DF @default.
- Q37335564 P2860 Q37335564-2DCA08F6-C335-4803-997C-F4F7263B5EA1 @default.
- Q37335564 P2860 Q37335564-2F21BEB7-AF0E-4D1F-859F-A426CFF09372 @default.
- Q37335564 P2860 Q37335564-3850F908-F04E-428A-B83A-9A4DD9945658 @default.
- Q37335564 P2860 Q37335564-3DD47862-8925-4B98-B43D-86FBE60A5AF0 @default.
- Q37335564 P2860 Q37335564-3E5E9A2E-71F9-4C26-9EB5-5CDE172371E4 @default.
- Q37335564 P2860 Q37335564-3F5077F7-F3AB-4E8F-924B-5EB76EE166B0 @default.
- Q37335564 P2860 Q37335564-446BC811-B743-43A6-905F-5F55D61B3267 @default.
- Q37335564 P2860 Q37335564-47D05830-78AA-4893-AAF9-50980803A444 @default.
- Q37335564 P2860 Q37335564-4804E281-DD97-44BF-8FD4-1CD90F3286EC @default.
- Q37335564 P2860 Q37335564-4859CC05-6507-4B92-AD21-07F9B69261EA @default.
- Q37335564 P2860 Q37335564-497A148F-342F-4D0C-AC6F-A87607B362AB @default.
- Q37335564 P2860 Q37335564-50CC14AE-A075-438B-83BD-7130EB87A2D5 @default.
- Q37335564 P2860 Q37335564-59245AA5-69FF-4271-A16A-CF87EBA7F57E @default.
- Q37335564 P2860 Q37335564-5EAC75DF-3820-43FC-98C8-D9E6FC5DCA2C @default.
- Q37335564 P2860 Q37335564-5F757681-B356-4B49-A290-D7568E365BB4 @default.
- Q37335564 P2860 Q37335564-6061463F-8171-4FDA-AE5A-6A3C4F0E3B19 @default.
- Q37335564 P2860 Q37335564-633FE91E-1BF0-4283-A3BD-7AE9DBAF4A44 @default.
- Q37335564 P2860 Q37335564-6D12F7FC-39DD-4BB8-80E5-1CDC528D14AB @default.
- Q37335564 P2860 Q37335564-71099B25-74FD-48A5-91AE-8CB9D3747D56 @default.
- Q37335564 P2860 Q37335564-74AE5C85-CEAD-4D23-AED0-DAD417A10E46 @default.
- Q37335564 P2860 Q37335564-76A304CD-502A-4F86-A5DD-41EE3F826DAE @default.
- Q37335564 P2860 Q37335564-81C141A7-B214-46C5-AD7A-EF22B9A1C65D @default.
- Q37335564 P2860 Q37335564-821EDB58-C586-4214-961D-6F686318BA93 @default.
- Q37335564 P2860 Q37335564-83B970E8-6403-4F2A-B3CD-CE600E89E414 @default.
- Q37335564 P2860 Q37335564-861CF530-CF50-4BC5-857B-243659FEE35D @default.
- Q37335564 P2860 Q37335564-8644179A-14A5-437F-AD5B-5EDD0179A7AA @default.
- Q37335564 P2860 Q37335564-8AB0C428-787D-486E-B31E-41026F627109 @default.
- Q37335564 P2860 Q37335564-9964C6D6-109F-470E-8CCB-FFA7ACB32EA6 @default.
- Q37335564 P2860 Q37335564-9D11F143-1C2D-4DB0-A146-32A7D8248E88 @default.
- Q37335564 P2860 Q37335564-A2AB5413-05A1-4462-8747-A057696EE48D @default.
- Q37335564 P2860 Q37335564-AA933F7E-DF1F-46BB-AAD3-6AA0C59F841D @default.
- Q37335564 P2860 Q37335564-AB5776C1-DD54-413E-A32F-D0900F5DC12E @default.
- Q37335564 P2860 Q37335564-ABB5DCB3-16CA-40DF-B9CA-FABC5E71C41E @default.
- Q37335564 P2860 Q37335564-B6F4CF2D-887D-4AEE-A339-5746A46FA20A @default.
- Q37335564 P2860 Q37335564-BA49885E-4DE8-4289-BA41-A6D30B30BF61 @default.
- Q37335564 P2860 Q37335564-BF1A2317-682F-46C3-B667-ABBB57F519E5 @default.
- Q37335564 P2860 Q37335564-C2961750-368E-4C15-960B-AD6F67680A70 @default.
- Q37335564 P2860 Q37335564-C359A517-FC10-4AA1-97C2-58E20CD308B4 @default.
- Q37335564 P2860 Q37335564-C6128AE6-CBE0-4D8C-A159-DF94CBD084A5 @default.
- Q37335564 P2860 Q37335564-CCB0E037-2375-4D9A-A868-6EB8A3BFA672 @default.
- Q37335564 P2860 Q37335564-D1352E1B-212C-4B77-BA38-C1A6A5F72694 @default.
- Q37335564 P2860 Q37335564-EA9A4124-8932-4A57-B77F-D8BB97C34D81 @default.
- Q37335564 P2860 Q37335564-F7EC5EBC-DE20-4BFD-896B-489AB2BFD75F @default.
- Q37335564 P2888 Q37335564-0E91BFDF-5E33-45EF-A68C-CC399A6BEC29 @default.
- Q37335564 P304 Q37335564-3ABEBD57-2496-4DE7-B27F-C4F1DEC7810E @default.
- Q37335564 P31 Q37335564-E282E80F-4C56-495A-A7FD-F2F22E969A4E @default.
- Q37335564 P356 Q37335564-787E420F-F5CA-482C-A9C7-7B20B4992E9F @default.
- Q37335564 P407 Q37335564-402379EA-D7E2-4C6F-8C27-61F6617B1DDD @default.
- Q37335564 P478 Q37335564-ED7B8842-38F5-47E2-832B-21CE060F3059 @default.
- Q37335564 P50 Q37335564-2B188107-260B-4E3E-98BF-F954C4BDC791 @default.
- Q37335564 P50 Q37335564-48A79069-9CEA-49F3-81CD-E01123035017 @default.
- Q37335564 P50 Q37335564-7C6C1CB5-0B1E-4632-8B03-32C790A08765 @default.
- Q37335564 P577 Q37335564-C473CEBF-A8F0-4F03-8571-CEB7855AFF4F @default.
- Q37335564 P698 Q37335564-ADEFE970-F0C1-44E8-8E40-C51FFB2028AF @default.
- Q37335564 P921 Q37335564-75E04716-1D55-430A-B048-290B794F1DBB @default.
- Q37335564 P932 Q37335564-51562DA1-D0D2-48F3-A1F9-8BA085CD8900 @default.
- Q37335564 P356 SREP35347 @default.
- Q37335564 P698 27734947 @default.
- Q37335564 P1433 Q2261792 @default.
- Q37335564 P1476 "Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy" @default.
- Q37335564 P2860 Q26851768 @default.
- Q37335564 P2860 Q27618903 @default.
- Q37335564 P2860 Q27620726 @default.
- Q37335564 P2860 Q27657200 @default.
- Q37335564 P2860 Q27679062 @default.
- Q37335564 P2860 Q27688055 @default.